· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
SHANGHAI PHARMA BIOTHERAPEUTICS — SHANGHAI PHARMA BIOTHERAPEUTICS USA INC, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250909051657NAL0033237536001
SHANGHAI PHARMA BIOTHERAPEUTICS
Form 5500-SF
FILING_RECEIVED
SHANGHAI PHARMA BIOTHERAPEUTICS USA INC
401(k) retirement plan
Active participants
9
Accounts w/ balance
11
Plan assets (EOY)
$1.8M
Net assets (EOY)
$1.8M
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
SHANGHAI PHARMA BIOTHERAPEUTICS
.
Find decision makers
Plan sponsor
Name
SHANGHAI PHARMA BIOTHERAPEUTICS
EIN
35-2638902
Address
3636 NOBEL DRIVE, STE 160 · SAN DIEGO, CA · 92122
Phone
(858) 735-8891
Industry
Professional & Technical Services
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-09-09
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Professional & Technical Services plans
BETA PHARMA USA, INC.
BETA PHARMA, INC. PROFIT SHARING PLAN
$1.8M · 11 participants
ENDOVASCULAR ENGINEERING, INC.
ENDOVASCULAR ENGINEERING, INC. 401(K) PLAN
$1.8M · 33 participants
EMPRESS THERAPEUTICS, INC
EMPRESS THERAPEUTICS, INC 401(K) PLAN
$1.8M · 41 participants
XAIRA THERAPEUTICS, INC.
XAIRA THERAPEUTICS, INC. 401(K) PLAN
$1.8M · 111 participants
CENTER FOR INNOVATIVE PUBLIC HEALTH RESEARCH, INC.
CIPHR 403(B) PLAN
100
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
$1.8M · 15 participants
CLINCON RESEARCH, INC.
CLINCON RESEARCH, INC. 401(K) PLAN
$1.8M · 1 participants
Large plans in California
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND
$215.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND E
$190.9B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND F
$188.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
RUSSELL 1000 INDEX FUND
$187.7B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
CASH EQUIVALENT FUND II
$125.0B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
BLACKROCK MSCI ACWI EX-US IMI INDEX FUND E
$88.3B
